MEPITEL NON-ADHERENT SILICONE DRESSING

K914604 · Molnlycke Clinical Products AB · NAB · Mar 25, 1992 · General, Plastic Surgery

Device Facts

Record IDK914604
Device NameMEPITEL NON-ADHERENT SILICONE DRESSING
ApplicantMolnlycke Clinical Products AB
Product CodeNAB · General, Plastic Surgery
Decision DateMar 25, 1992
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 878.4014
Device ClassClass 1
AttributesTherapeutic

Device Story

Mepitel is a non-adherent silicone dressing used for wound management. It functions as a protective interface between the wound bed and secondary dressings to prevent adherence. It is applied by clinicians or patients in clinical or home settings. The device does not accelerate healing or serve as a skin substitute. It facilitates dressing changes by minimizing trauma to the wound site.

Clinical Evidence

No clinical data provided; substantial equivalence based on administrative review of pre-1976 market status.

Technological Characteristics

Non-adherent silicone dressing. Class I device (Product Code NAB).

Indications for Use

Indicated for use as a non-adherent wound dressing. Not indicated for third-degree burns, accelerating wound healing/epithelization, long-term/permanent dressing, artificial/synthetic skin, or treatment/cure for vascular stasis ulcers without specific FDA approval.

Regulatory Classification

Identification

A nonresorbable gauze/sponge for external use is a sterile or nonsterile device intended for medical purposes, such as to be placed directly on a patient's wound to absorb exudate. It consists of a strip, piece, or pad made from open woven or nonwoven mesh cotton cellulose or a simple chemical derivative of cellulose. This classification does not include a nonresorbable gauze/sponge for external use that contains added drugs such as antimicrobial agents, added biologics such as growth factors, or is composed of materials derived from animal sources.

Submission Summary (Full Text)

{1} ![LOGO](FDA U.S. FOOD & DRUG ADMINISTRATION) April 9, 2024 Swedish Trade Council, U.S.A. for Molnlycke Clinical Products AB Sven E. Sievers Market Consultant, Health Care 150 North Michigan Ave, Suite 1200 Chicago, Illinois 60601 Re: K914604 Trade/Device Name: Mepitel (Non-Adherent Silicone Dressing) Regulation Number: 21 CFR 878.4014 Regulation Name: Nonresorbable gauze/sponge for external use Regulatory Class: Class I Product Code: NAB Dear Sven E. Sievers: The Food and Drug Administration (FDA) is sending this letter to notify you of an administrative change related to your previous substantial equivalence (SE) determination letter dated March 25, 1992. Specifically, FDA is updating this SE Letter because FDA has better categorizes your device technology under product code NAB. Please note that the 510(k) submission was not re-reviewed. For questions regarding this letter please contact Yu-Chieh Chiu, OHT4: Office of Surgical and Infection Control Devices, 301-796-6196, yu-chieh.chiu@fda.hhs.gov. Sincerely, Yu-chieh Chiu -S Yu-Chieh Chiu, Ph.D. Assistant Director DHT4B: Division of Infection Control and Plastic Surgery Devices OHT4: Office of Surgical and Infection Control Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health U.S. Food & Drug Administration 10903 New Hampshire Avenue Silver Spring, MD 20993 www.fda.gov {2} [LOGO] DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service MAR 25 1992 Food and Drug Administration 1390 Piccard Drive Rockville, MD 20850 Mr. Sven E. Sievers Market Consultant Health Care Swedish Trade Council, U.S.A. for Molnlycke Clinical Products AB 150 North Michigan Avenue Suite 1200 Chicago, Illinois 60601-7564 Re: K914604 Mepitel (Non-Adherent Silicone Dressing) Regulatory Class: Unclassified Dated: December 18, 1991 Received: December 30, 1991 Dear Mr. Sievers: We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments. You may, therefore, market your device subject to the general controls provisions of the Federal Food, Drug, and Cosmetic Act (Act) and the following limitations: 1. This device may not be labeled for use on third degree burns without specific Food and Drug Administration (FDA) approval for such labeling. 2. This device may not be labeled as having any accelerating effect on the rate of wound healing or epithelization without evidence of said effect being reviewed and approved by FDA. 3. This device may not be labeled as a long-term or permanent, no change dressing, or as an artificial or synthetic skin without specific FDA approval for such labeling. 4. This device may not be labeled as a treatment or a cure for vascular stasis ulcers without specific FDA approval for such labeling. {3} Page 2 - Mr. Sven E. Sievers The general controls provisions of the Act include requirements for registration, listing of devices, good manufacturing practice, and labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval) it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under the Radiation Control for Health and Safety Act of 1968, or other Federal Laws or Regulations. This letter immediately will allow you to begin marketing your device as described. An FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and permits your device to proceed to the market, but it does not mean that FDA approves your device. Therefore, you may not promote or in any way represent your device or its labeling as being approved by FDA. If you desire specific advice on the labeling for your device please contact the Division of Compliance Operations, Regulatory Guidance Branch (HFZ-323) at (301) 427-1116. Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at their toll free number (800) 638-2041 or at (301) 443-6597. Sincerely yours, Philip J. Phillips Interim Director Division of General and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health 2
Innolitics
Guidance Recalls

Panel 1

/
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...